Back

Urinary microRNA Profiles Discriminate Bladder Cancer from Healthy Individuals: A Pilot Study Using qPCRAcross Urine Fractions.

Duarte, C. A. B.; Leitao, K.; Hokazono, S. R.; Eduardo Varaschin, A.; Nakatani, S. M.

2025-08-24 genetic and genomic medicine
10.1101/2025.08.19.25333993 medRxiv
Show abstract

The development of reliable non-invasive diagnostic tools for bladder cancer remains a significant challenge. We hypothesized that the combined quantification of selected urinary microRNAs could differentiate bladder cancer cases from healthy controls. Using qPCR, we analyzed five candidate microRNAs (miR-21-5p, miR-141-3p, miR-210-3p, miR-200a-3p, and miR-103-3p) across three urine fractions: whole urine, pellet, and supernatant from a small cohort (n = 9). Although individual gene expression differences between cases and controls were not statistically significant (Wilcoxon p > 0.05), multivariate clustering using Mclust modeling and PCA showed clear separation, especially in the whole urine fraction. These results suggest that combined miRNA expression profiling, rather than individual markers, may provide diagnostic value for bladder cancer. Even though further evaluation in a larger population is necessary, our findings indicate that a cost-effective and easily implementable non-invasive diagnostic approach for bladder cancer may be within reach.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.